BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012

Nov 19, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-11-15

Reporting Person: Mueller Brian (VP, Corporate Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-11-15	Common Stock	M	5500	$14.39	Acquired	20840	Direct
2012-11-15	Common Stock	M	10312	$38.59	Acquired	31152	Direct
2012-11-15	Common Stock	S	15812	$50.00	Disposed	15340	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-11-15	Stock Option (right to buy) Common Stock	$14.39	M	5500	Disposed	2019-05-11	Common Stock (5500)	Direct
2012-11-15	Stock Option (right to buy) Common Stock	$38.59	M	10312	Disposed	2018-05-21	Common Stock (10312)	Direct

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 Trading plan executed on March 8, 2012.

F2: Original option grant vests 6/48th on November 12, 2009 and 1/48th each on the 12th of each month thereafter.

F3: Original option grant vests 6/48th on November 22, 2008 and 1/48th each on the 22nd of each month thereafter.